Exagen Inc.XGNNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank77
5Y CAGR+11.4%
Studio
Year-over-Year Change

Year-over-year net income growth rate

5Y CAGR
+11.4%/yr
Long-term compound
Percentile
P77
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 202534.06%
Q3 2025-59.65%
Q2 2025-18.31%
Q1 20250.24%
Q4 202425.20%
Q3 2024-69.52%
Q2 202411.73%
Q1 202439.71%
Q4 2023-2.92%
Q3 2023-8.02%
Q2 202334.79%
Q1 202346.44%
Q4 2022-77.30%
Q3 202244.79%
Q2 2022-42.77%
Q1 2022-45.64%
Q4 20211.76%
Q3 2021-12.00%
Q2 2021-3.24%
Q1 2021-79.81%
Q4 202019.85%
Q3 2020-28.10%
Q2 202039.55%
Q1 2020-63.23%
Q4 2019-8.50%
Q3 2019-12.78%
Q2 2019-3.00%
Q1 2019-105.32%
Q4 201825.00%
Q3 201860.61%
Q2 201816.31%
Q1 20180.00%
Q4 201527.75%
Q3 201563.80%
Q2 2015-180.10%
Q1 2015-32.54%
Q4 201445.79%
Q3 2014-20.57%
Q2 2014-11.91%
Q1 201444.76%